These results indicate that endogenous SPARC may act as a tumour suppressor in PDAC cells, a function SPARC also has in ovarian, neuroblastomas, and colorectal cancers (Tai and Tang, 2008). The gene discussed is SPARC; the disease is neuroblastoma.